News
9hon MSN
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
8h
ABC13 Houston on MSNUS Food and Drug Administration to review injectable medication to prevent HIV transmissionThe Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has shown ...
Nearly 1 in 5 positions across the Food and Drug Administration's human food inspection divisions are now vacant, multiple ...
The Food and Drug Administration has approved three naturally sourced food dyes. For more on what this may mean for your ...
A new agreement between the FDA and Avidity Biosciences could further assuage industry concerns about the agency’s stance on ...
Layoffs at the FDA, USDA and CDC could erode the U.S. food safety system. Experts aren’t so worried about milk or chicken today; they’re concerned about the future.
Usnoflast is an orally available small molecule that's designed to reduce inflammation, a key contributor to nerve cell ...
Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...
When Secretary of Health and Human Services Robert F. Kennedy Jr. announced an artificial food dye ban, it was difficult to ...
17h
FOX 8 News on MSNFungi concerns spark nationwide recall of Zicam and Orajel productsAccording to the U.S. Food and Drug Administration, Church & Dwight Co., Inc. is voluntarily recalling some Zicam® and Orajel™ products because fungi could be present in the items’ ...
Days after the Food and Drug Administration (FDA) suspended the food business licence of Zepto’s warehouse in Mumbai’s ...
TuHURA Biosciences said its carcinoma therapy trials can continue now that health regulators have removed the partial clinical hold on the treatment tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results